These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 28489822)
1. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Wang B; Jie Z; Joo D; Ordureau A; Liu P; Gan W; Guo J; Zhang J; North BJ; Dai X; Cheng X; Bian X; Zhang L; Harper JW; Sun SC; Wei W Nature; 2017 May; 545(7654):365-369. PubMed ID: 28489822 [TBL] [Abstract][Full Text] [Related]
2. Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1. Ghomlaghi M; Yang G; Shin SY; James DE; Nguyen LK PLoS Comput Biol; 2021 Sep; 17(9):e1008513. PubMed ID: 34529665 [TBL] [Abstract][Full Text] [Related]
3. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Liu P; Gan W; Inuzuka H; Lazorchak AS; Gao D; Arojo O; Liu D; Wan L; Zhai B; Yu Y; Yuan M; Kim BM; Shaik S; Menon S; Gygi SP; Lee TH; Asara JM; Manning BD; Blenis J; Su B; Wei W Nat Cell Biol; 2013 Nov; 15(11):1340-50. PubMed ID: 24161930 [TBL] [Abstract][Full Text] [Related]
4. PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex. Liu P; Gan W; Chin YR; Ogura K; Guo J; Zhang J; Wang B; Blenis J; Cantley LC; Toker A; Su B; Wei W Cancer Discov; 2015 Nov; 5(11):1194-209. PubMed ID: 26293922 [TBL] [Abstract][Full Text] [Related]
5. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells. Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235 [TBL] [Abstract][Full Text] [Related]
7. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism. Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304 [TBL] [Abstract][Full Text] [Related]
8. Dual phosphorylation of Sin1 at T86 and T398 negatively regulates mTORC2 complex integrity and activity. Liu P; Guo J; Gan W; Wei W Protein Cell; 2014 Mar; 5(3):171-7. PubMed ID: 24481632 [TBL] [Abstract][Full Text] [Related]
9. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells. Misra UK; Pizzo SV PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152 [TBL] [Abstract][Full Text] [Related]
11. Cystine Induced-mTORC2 Activation through Promoting Sin1 Phosphorylation to Suppress Cancer Cell Ferroptosis. Wang G; Chen L; Qin S; Zheng Y; Xia C; Yao J; Wang P; Deng L Mol Nutr Food Res; 2022 Dec; 66(23):e2200186. PubMed ID: 36189894 [TBL] [Abstract][Full Text] [Related]
12. Disruption of the Scaffolding Function of mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2-Dependent Tumor Growth Hwang Y; Kim LC; Song W; Edwards DN; Cook RS; Chen J Cancer Res; 2019 Jul; 79(13):3178-3184. PubMed ID: 31085701 [TBL] [Abstract][Full Text] [Related]
13. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906 [TBL] [Abstract][Full Text] [Related]
14. Maternal hyperglycemia inhibits pulmonary vasculogenesis during mouse fetal lung development by promoting GβL Ubiquitination-dependent mammalian target of Rapamycin assembly. Luo Q; Chai X; Xin X; Ouyang W; Deng F Diabetol Metab Syndr; 2023 Mar; 15(1):49. PubMed ID: 36927703 [TBL] [Abstract][Full Text] [Related]
15. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). García-Martínez JM; Alessi DR Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875 [TBL] [Abstract][Full Text] [Related]
16. Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin. Zou Z; Chen J; Yang J; Bai X Curr Cancer Drug Targets; 2016; 16(4):288-304. PubMed ID: 26563881 [TBL] [Abstract][Full Text] [Related]
17. A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation. Yang G; Murashige DS; Humphrey SJ; James DE Cell Rep; 2015 Aug; 12(6):937-43. PubMed ID: 26235620 [TBL] [Abstract][Full Text] [Related]
18. mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8. Kim SJ; DeStefano MA; Oh WJ; Wu CC; Vega-Cotto NM; Finlan M; Liu D; Su B; Jacinto E Mol Cell; 2012 Dec; 48(6):875-87. PubMed ID: 23142081 [TBL] [Abstract][Full Text] [Related]
19. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma. Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736 [TBL] [Abstract][Full Text] [Related]
20. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship. Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]